Integrated anti-remodeling and anabolic therapy for the osteoporosis of Hajdu-Cheney syndrome: 2-year follow-up.
McKiernan
F E
FE
D000328:Adult; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D016723:Bone Remodeling / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D031845:Hajdu-Cheney Syndrome / Q000188:drug therapy*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*
D050071:Bone Density Conservation Agents